R-CMOP in Patients With Primary Diffuse Large B-cell Lymphoma
Status:
Not yet recruiting
Trial end date:
2024-08-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of R-CMOP regimen based on mitoxantrone hydrochloride
liposome injection in the treatment of newly diagnosed diffuse large B-cell lymphoma (DLBCL)
based on cardiac function screening
Phase:
N/A
Details
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University